Search alternatives:
point decrease » point increase (Expand Search)
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a point » _ point (Expand Search), 5 point (Expand Search), _ points (Expand Search)
point decrease » point increase (Expand Search)
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a point » _ point (Expand Search), 5 point (Expand Search), _ points (Expand Search)
-
13421
-
13422
-
13423
Evaluation of PIT effects in a disseminated peritoneal model.
Published 2014“…<p>(A) PIT regimen. Real-time GFP fluorescence imaging was obtained at each time point indicated. …”
-
13424
Presentation 1_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhi...
Published 2025“…Treatment with Nu0.5 resulted in a numerically decreased EASI score (-11.9%, [-34.9%, 11.1%], p > 0.05), which is comparable with placebo group (-2.9%, [-21.5%, 15.6%], p > 0.05). …”
-
13425
Presentation 3_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhi...
Published 2025“…Treatment with Nu0.5 resulted in a numerically decreased EASI score (-11.9%, [-34.9%, 11.1%], p > 0.05), which is comparable with placebo group (-2.9%, [-21.5%, 15.6%], p > 0.05). …”
-
13426
Data Sheet 1_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhibi...
Published 2025“…Treatment with Nu0.5 resulted in a numerically decreased EASI score (-11.9%, [-34.9%, 11.1%], p > 0.05), which is comparable with placebo group (-2.9%, [-21.5%, 15.6%], p > 0.05). …”
-
13427
Data Sheet 2_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhibi...
Published 2025“…Treatment with Nu0.5 resulted in a numerically decreased EASI score (-11.9%, [-34.9%, 11.1%], p > 0.05), which is comparable with placebo group (-2.9%, [-21.5%, 15.6%], p > 0.05). …”
-
13428
Presentation 2_A phase 2a double-blind, placebo-controlled, randomized clinical trial evaluating the efficacy and safety of NuGel, a novel topical GPCR19-mediated inflammasome inhi...
Published 2025“…Treatment with Nu0.5 resulted in a numerically decreased EASI score (-11.9%, [-34.9%, 11.1%], p > 0.05), which is comparable with placebo group (-2.9%, [-21.5%, 15.6%], p > 0.05). …”
-
13429
-
13430
-
13431
Calcium levels in PC12 cells exposed to SMF, the A<sub>2A</sub>R agonist CGS21680 or antagonist ZM241385.
Published 2013“…<p>(<b>A</b>) Extracellular Ca<sup>2+</sup> was measured for cells maintained in calcium-free medium increased for time points up to 3.0 h in response to SMF exposure; <i>p</i><0.05 for n = 3 independent experiments. …”
-
13432
-
13433
RNA expression of <i>KRT6, KRT10, S100A8, S100A9, p21, and HMOX-1</i>.
Published 2011“…<i>KRT10</i> showed a tendency to decrease (statistically not significant) in all treated samples. …”
-
13434
Gonadal development and sex ratios as a function of TL.
Published 2013“…</p> <p>(b) Sex ratios (female:male) as a function of TL. Data were sorted into 50 mm TL intervals. …”
-
13435
Closed loop stimulation (CLS) simulation results.
Published 2024“…<p><b><i>A</i></b>, Power spectral density (PSD) of the cortical LFP across a 300 s time period with “Point 1” (green), “Point 4” stimulation (red), and Control (black) simulation. …”
-
13436
Data_Sheet_1_Short Practical Regimen of Acupuncture for Melasma: A Prospective Cohort Study in a Tertiary Hospital in Thailand.PDF
Published 2021“…At 1 week after five sessions of acupuncture in Group A, the mean MI decreased by 28.7 (95% CI −38.5 to −18.8, p < 0.001), whereas the median MASI decreased by 3.4 (95% CI −6.9 to −1.2, p < 0.001) points. …”
-
13437
-
13438
-
13439
Image1_A 12-week lifestyle intervention: effects on fatigue, fear, and nutritional status in children with a Fontan circulation.pdf
Published 2023“…Before training, fear regarding exercise scored on the fear thermometer was low for both children and parents (median score 1 and 2, respectively, on a scale of 0–8). After training, child-reported fear decreased further compared to the control period [effect size −1.4 points (−2.3 to −0.6), p = 0.001]. …”
-
13440
Developmental changes in connectivity strength are not a function of distance.
Published 2016“…(B) Each point represents a pairwise relationship between two regions of interest. …”